Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bausch & Lomb
MedTech
Bausch + Lomb identifies cause of intraocular lens recall
The recall of intraocular lenses is currently being wrapped up by Bausch + Lomb, after reports of inflammatory reactions following cataract surgery.
Conor Hale
May 6, 2025 11:30am
Eye disease biotech looks to clinical trials with $93M series B
Mar 25, 2025 8:00am
Bausch + Lomb pens $485M-plus biobucks pact with City Tx
Jan 10, 2025 6:37am
Eikon builds out clinical development team—Chutes & Ladders
Jun 2, 2023 9:30am
Bausch + Lomb exec to depart—Chutes & Ladders
Apr 14, 2023 9:30am
Sanofi's John Reed jumps ship for J&J—Chutes & Ladders
Feb 17, 2023 9:30am